


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app29.us.archive.org';v.server_ms=564;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>Stroke: percentage of ischemic stroke patients who develop a symptomatic intracranial hemorrhage within (less than or equal to) 36 hours after the onset of treatment with IV or IA thrombolytic (t-PA) therapy, or mechanical endovascular reperfusion procedure. | National Quality Measures Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/favicon-NQMC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/apple-touch-icon-NQMC.png">
    <link rel="icon" type="image/png" href="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/favicon-NQMC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/favicon-NQMC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/UI/images/manifest-NQMC.json">
    <link rel="mask-icon" href="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/safari-pinned-tab-NQMC.svg" color="#222c66">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180620213610cs_/https://www.qualitymeasures.ahrq.gov/cassette.axd/stylesheet/50802fec44b49e78c77b55e1df8361e3dbe9a339/NQMCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180620213610js_/https://dap.digitalgov.gov/Universal足-Federated-足Analytics-足Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180620213610if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180620213610/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180620213610if_/https://www.googletagmanager.com/ns.html?id=GTM-KXQCDQ" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180620213610/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KXQCDQ');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180620213610/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180620213610/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/" class="header-logo NQMC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_header.png">
				        <source srcset="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_header_m.png">
				        <img src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_header.png" alt="National Quality Measures Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NQMC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/">Home</a></li>
		        <li class=""><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/new-this-week/index">New This Week</a></li>
		        <li>
                    <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/browse" class="parent-link">Measure Summaries</a>		            <ul class="level-2 dropdown">
		                    <li class=""><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/browse/domain">By Measure Domain</a></li>
                            <li class=""><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/browse/setting">By Measurement Setting</a></li>
		                <li class=""><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_DocType=302&amp;fLockTerm=Measure Summaries">All Summaries</a></li>
		            </ul>
		        </li>
		        <li class=""><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/matrix">Matrix Tool</a></li>
		        <li class="">
                    <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/submit">Submit Measures</a>		        </li>
                <li class=""><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Quality Measures Clearinghouse (NQMC, qualitymeasures.ahrq.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NQMC as of that date. For additional information, read our <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Measure Summary</li>
            <li>NQMC:009994</li>
            <li>Mar 2015
            </li>            
                                </ul>
        <div>
                <h1>Stroke: percentage of ischemic stroke patients who develop a symptomatic intracranial hemorrhage within (less than or equal to) 36 hours after the onset of treatment with IV or IA thrombolytic (t-PA) therapy, or mechanical endovascular reperfusion procedure.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_Developer_String=The%20Joint%20Commission&amp;fLockTerm=The%2BJoint%2BCommission">The Joint Commission</a></li>
                        <li>   
                                <a id="10" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>The Joint Commission. Disease-specific care certification program. Comprehensive stroke: performance measurement implementation guide. Oakbrook Terrace (IL): The Joint Commission; 2015 Mar. 278 p. </td></tr></table>                    <p><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/Home/Disclaimer?id=48910&amp;contentType=fulltextlink&amp;redirect=http%253a%252f%252fwww.jointcommission.org%252fassets%252f1%252f6%252fCSTK_Manual_Mar2015.pdf">View the original measure documentation</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the measure.</p>
<p>The measure developer reaffirmed the currency of this measure in April 2016. </p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
            <h4>Measure Hierarchy</h4>
<a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_Collection_Hierarchy=objid48904&amp;fLockTerm=Advanced%2BCertification%2Bin%2BDisease-specific%2BCare%2BMeasures">Advanced Certification in Disease-specific Care Measures</a> &gt; <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_Collection_Hierarchy=objid48904%3Bobjid48905&amp;fLockTerm=Comprehensive%2BStroke%2BStandardized%2BPerformance%2BMeasures">Comprehensive Stroke Standardized Performance Measures</a>                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Adult%3A%2080%20years%20old%20and%20older&amp;fLockTerm=Adult%253a%2B80%2Byears%2Bold%2Band%2Bolder">Adult: 80 years old and older</a></li>                                              
                        <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Adult%3A%2065-79%20years%20old&amp;fLockTerm=Adult%253a%2B65-79%2Byears%2Bold">Adult: 65-79 years old</a></li>                                              
                        <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Adult%3A%2045-64%20years%20old&amp;fLockTerm=Adult%253a%2B45-64%2Byears%2Bold">Adult: 45-64 years old</a></li>                                              
                        <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Adult%3A%2019-44%20years%20old&amp;fLockTerm=Adult%253a%2B19-44%2Byears%2Bold">Adult: 19-44 years old</a></li>                                              
                        <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_Target_Population_Age=Adolescent%3A%2013-18%20years%20old&amp;fLockTerm=Adolescent%253a%2B13-18%2Byears%2Bold">Adolescent: 13-18 years old</a></li>                                              
            </ul>
                    <h4>UMLS Concepts <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_ICD9CM_CUI=C0151699&amp;fLockTerm=Unspecified+intracranial+hemorrhage">Unspecified intracranial hemorrhage</a>
 (432.9)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0007786&amp;fLockTerm=Brain+Ischemia">Brain Ischemia</a>
, <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C2936204&amp;fLockTerm=Endovascular+Procedures">Endovascular Procedures</a>
, <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0151699&amp;fLockTerm=Intracranial+Hemorrhages">Intracranial Hemorrhages</a>
, <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0035124&amp;fLockTerm=Reperfusion">Reperfusion</a>
, <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0038454&amp;fLockTerm=Stroke">Stroke</a>
, <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0040225&amp;fLockTerm=Time+Factors">Time Factors</a>
, <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_MSH_CUI=C0032143&amp;fLockTerm=Tissue+Plasminogen+Activator">Tissue Plasminogen Activator</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0032143&amp;fLockTerm=alteplase">alteplase</a>
, <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0007786&amp;fLockTerm=Brain+Ischemia">Brain Ischemia</a>
, <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0038454&amp;fLockTerm=Cerebrovascular+accident">Cerebrovascular accident</a>
, <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_MTH_CUI=C0035124&amp;fLockTerm=Reperfusion+Therapy">Reperfusion Therapy</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_PDQ_CUI=C0032143&amp;fLockTerm=recombinant+tissue+plasminogen+activator">recombinant tissue plasminogen activator</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0032143&amp;fLockTerm=Alteplase">Alteplase</a>
 (108997009), <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0032143&amp;fLockTerm=Alteplase">Alteplase</a>
 (27638005), <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0032143&amp;fLockTerm=Alteplase">Alteplase</a>
 (37411004), <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0032143&amp;fLockTerm=Alteplase">Alteplase</a>
 (387152000), <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0038454&amp;fLockTerm=Cerebrovascular+accident">Cerebrovascular accident</a>
 (230690007), <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0151699&amp;fLockTerm=Intracranial+hemorrhage">Intracranial hemorrhage</a>
 (1386000), <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/search?f_SNOMEDCT_US_CUI=C0007786&amp;fLockTerm=Ischemic+encephalopathy">Ischemic encephalopathy</a>
 (389100007)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#563" class="section-mark">Measure Domain</a></li>
                                    <li><a href="#566" class="section-mark">Brief Abstract</a></li>
                                    <li><a href="#573" class="section-mark">Evidence Supporting the Measure</a></li>
                                    <li><a href="#580" class="section-mark">State of Use of the Measure</a></li>
                                    <li><a href="#583" class="section-mark">Application of the Measure in its Current Use</a></li>
                                    <li><a href="#660" class="section-mark">National Strategy for Quality Improvement in Health Care</a></li>
                                    <li><a href="#590" class="section-mark">Institute of Medicine (IOM) National Health Care Quality Report Categories</a></li>
                                    <li><a href="#593" class="section-mark">Data Collection for the Measure</a></li>
                                    <li><a href="#605" class="section-mark">Computation of the Measure</a></li>
                                    <li><a href="#615" class="section-mark">Identifying Information</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/downloadcontent/nqmc-9994?contentType=pdf" class="pdf">.PDF 105.9 kb</a></li>
                            <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/downloadcontent/nqmc-9994?contentType=word" class="word">Word Document 291.6 kb</a></li>
                            <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/downloadcontent/nqmc-9994?contentType=xml" class="xml">.XML 39.5 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180620213610/https://www.facebook.com/sharer/sharer.php?u=https://www.qualitymeasures.ahrq.gov/summaries/summary/48910/stroke-percentage-of-ischemic-stroke-patients-who-develop-a-symptomatic-intracranial-hemorrhage-within-less-than-or-equal-to-36-hours-after-the-onset-of-treatment-with-iv-or-ia-thrombolytic-tpa-therapy-or-mechanical-endovascular-reperfusion-procedure" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180620213610/https://twitter.com/share?text=&amp;url=https://www.qualitymeasures.ahrq.gov/summaries/summary/48910/stroke-percentage-of-ischemic-stroke-patients-who-develop-a-symptomatic-intracranial-hemorrhage-within-less-than-or-equal-to-36-hours-after-the-onset-of-treatment-with-iv-or-ia-thrombolytic-tpa-therapy-or-mechanical-endovascular-reperfusion-procedure" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180620213610/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.qualitymeasures.ahrq.gov/summaries/summary/48910/stroke-percentage-of-ischemic-stroke-patients-who-develop-a-symptomatic-intracranial-hemorrhage-within-less-than-or-equal-to-36-hours-after-the-onset-of-treatment-with-iv-or-ia-thrombolytic-tpa-therapy-or-mechanical-endovascular-reperfusion-procedure&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180620213610/mailto:/?Subject=AHRQ: Stroke: percentage of ischemic stroke patients who develop a symptomatic intracranial hemorrhage within (less than or equal to) 36 hours after the onset of treatment with IV or IA thrombolytic (t-PA) therapy, or mechanical endovascular reperfusion procedure.&amp;body=https://www.qualitymeasures.ahrq.gov/summaries/summary/48910/stroke-percentage-of-ischemic-stroke-patients-who-develop-a-symptomatic-intracranial-hemorrhage-within-less-than-or-equal-to-36-hours-after-the-onset-of-treatment-with-iv-or-ia-thrombolytic-tpa-therapy-or-mechanical-endovascular-reperfusion-procedure" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Quality Measures Clearinghouse (NQMC). Measure summary: Stroke: percentage of ischemic stroke patients who develop a symptomatic intracranial hemorrhage within (less than or equal to) 36 hours after the onset of treatment with IV or IA thrombolytic (t-PA) therapy, or mechanical endovascular reperfusion procedure. In: National Quality Measures Clearinghouse (NQMC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2015 Mar 01. [cited 2018 Jun 20]. Available: https://www.qualitymeasures.ahrq.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/48910?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/48910?format=enw">EndNote</a></li>
                            <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/48910?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/48910?format=txt">Medlars</a></li>
                            <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/48910?format=ris">ProCite</a></li>
                            <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/48910">RefWorks</a></li>
                            <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/citedownload/48910?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="48910" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="563" class="accordion-title section-563 is-active" role="tab" aria-expanded="true"><a href="#">Measure Domain</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Primary Measure Domain</a></h3>
                    <p>Clinical Quality Measures: Outcome</p>
                        <h3><a href="#">Secondary Measure Domain</a></h3>
                    <p>Does not apply to this measure</p>

            </div>
                <h2 id="566" class="accordion-title section-566 is-active" role="tab" aria-expanded="true"><a href="#">Brief Abstract</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description</a></h3>
                    <p><div class="content_para"><p>This measure is used to assess the percentage of ischemic stroke patients who develop a symptomatic intracranial hemorrhage (i.e., clinical deterioration greater than or equal to 4 point increase on National Institutes of Health Stroke Scale [NIHSS] and brain image finding of parenchymal hematoma, or subarachnoid hemorrhage, or intraventricular hemorrhage) within (less than or equal to) 36 hours after the onset of treatment with intravenous (IV) or intra-arterial (IA) thrombolytic (t-PA) therapy, or mechanical endovascular reperfusion procedure (i.e., mechanical endovascular thrombectomy with a clot retrieval device).</p>
<p>This measure represents the overall rate. The following rates are also reported:</p>
<ul style="list-style-type: disc;">
    <li>Hemorrhagic transformation for patients treated with intra-venous (IV) thrombolytic (t-PA) therapy only </li>
    <li>Hemorrhagic transformation for patients treated with intra-arterial (IA) thrombolytic (t-PA) therapy or mechanical endovascular reperfusion therapy </li>
</ul></div></p>
                        <h3><a href="#">Rationale</a></h3>
                    <p><div class="content_para"><p>Intravenous (IV) thrombolytic (t-PA) therapy for acute ischemic stroke was approved by the U.S. Food and Drug Administration in 1996, following findings from the National Institute of Neurological Disorders and Stroke (NINDS) trial which demonstrated favorable outcomes in 31% to 50% of patients treated with recombinant tissue plasminogen activator (r-tPA), as compared to 20% to 38% of patients treated with placebo. Intra-arterial (IA) t-PA therapy has since been used to improve recanalization and clinical outcomes for select patients nonresponsive to IV therapy. Intracranial hemorrhage is the major risk of t-PA therapy with similar rates reported for both IV and IA routes. The NINDS trial found that 6.4% of patients treated with IV t-PA experienced symptomatic bleeding. Findings from the Prolyse in Acute Cerebral Thromboembolism (PROACT II) study found the intracranial hemorrhage with neurological deterioration within 24 hours occurred in 10% of patients treated with IA recombinant prourokinase. In addition to these agents, other available thrombolytic drugs include: streptokinase, p-anisoylated lys-plasminogen-streptokinase activator, and urokinase.</p>
<p>Endovascular reperfusion therapy in acute ischemic stroke comprises a number of pharmacological and mechanical procedures. Mechanical endovascular thrombectomy is a treatment option for patients with large vessel occlusions in whom pharmacological thrombolysis is contraindicated or might be ineffective. A number of mechanical endovascular thrombectomy devices, also known as clot retrieval devices, are currently undergoing clinical evaluation. Mechanical endovascular thrombectomy devices are intended to improve tissue rescue and diminish reperfusion hemorrhage while broadening the population eligible for therapy. These devices may be used alone or in conjunction with chemical thrombolysis (i.e., IV or IA t-PA).</p></div></p>
                        <h3><a href="#">Evidence for Rationale</a></h3>
                    <p><table><tr><td>Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council. Circulation. 1996 Sep 1;94(5):1167-74. [102 references] <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8790069" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF, American Heart Association, American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interd[TRUNC]. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007 May;38(5):1655-711. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17431204" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, von Kummer R, Molina CA, Demaerschalk BM, Budzik R, Clark WM, Zaidat OO, Malisch TW, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson C, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Martin RH, Foster LD, Tomsick TA, Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013 Mar 7;368(10):893-903. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=23390923" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, Boccardi E, SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013 Mar 7;368(10):904-13. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=23387822" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Gent M, Driscoll RM, PROACT Investigators. The Prolyse in Acute Cerebral Thromboembolism Trial (PROACT): results of 6 mg dose tier. Stroke. 1996;27:164.</td></tr></table></p>
                    <p><table><tr><td>del Zoppo GJ, Higashida RT, Furlan AJ. The case for a phase III trial of cerebral intraarterial fibrinolysis. AJNR Am J Neuroradiol. 1994;15:1217-22.</td></tr></table></p>
                    <p><table><tr><td>Donnan GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, McNeil JJ, Rosen D, Stewart-Wynne EG, Tuck RR. Trials of streptokinase in severe acute ischaemic stroke. Lancet. 1995 Mar 4;345(8949):578-9. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7776784" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Fibrinolytic Therapy Trialists' (FFT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994 Feb 5;343(8893):311-22. [58 references] <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7905143" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute  hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995 Oct 4;274(13):1017-25. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7563451" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H, American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Peripheral Vascular Disease, Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013 Mar;44(3):870-947. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=23370205" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, Feng L, Meyer BC, Olson S, Schwamm LH, Yoo AJ, Marshall RS, Meyers PM, Yavagal DR, Wintermark M, Guzy J, Starkman S, Saver JL, MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013 Mar 7;368(10):914-23. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=23394476" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Koh JS, Lee SJ, Ryu CW, Kim HS. Safety and efficacy of mechanical thrombectomy with solitaire stent retrieval for acute ischemic stroke: a systematic review. Neurointervention. 2012 Feb;7(1):1-9. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22454778" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Leifer D, Bravata DM, Connors JJ, Hinchey JA, Jauch EC, Johnston SC, Latchaw R, Likosky W, Ogilvy C, Qureshi AI, Summers D, Sung GY, Williams LS, Zorowitz R, American Heart Association Special Writing Group of the Stroke Council, Atherosclerotic Peripheral Vascular Disease Working Group, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Nursing. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011 Mar;42(3):849-77. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21233469" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Levy DE, Brott TG, Haley EC, Marler JR, Sheppard GL, Barsan W, Broderick JP. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke. 1994 Feb;25(2):291-7.</td></tr></table></p>
                    <p><table><tr><td>Marder VJ, Sherry S. Thrombolytic therapy: current status (1). N Engl J Med. 1988 Jun 9;318(23):1512-20. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3285216" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Menon BK, Saver JL, Prabhakaran S, Reeves M, Liang L, Olson DM, Peterson ED, Hernandez AF, Fonarow GC, Schwamm LH, Smith EE. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke. 2012 Sep;43(9):2293-9. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22811458" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, Liebeskind DS, Smith WS, TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012 Oct 6;380(9849):1231-40. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22932714" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group. Lancet. 1995 Dec 9;346(8989):1509-14. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7491044" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Rubiera M, Ribo M, Pagola J, Coscojuela P, Rodriguez-Luna D, Maisterra O, Ibarra B, Pi単eiro S, Meler P, Romero FJ, Alvarez-Sabin J, Molina CA. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study. Stroke. 2011 Apr;42(4):993-7. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=21372307" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, Clark W, Budzik R, Zaidat OO, SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012 Oct 6;380(9849):1241-9. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=22932715" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Sims JR, Gharai LR, Schaefer PW, Vangel M, Rosenthal ES, Lev MH, Schwamm LH. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology. 2009 Jun 16;72(24):2104-10. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19528517" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Sloan MA, Price TR, Petito CK, Randall AM, Solomon RE, Terrin ML, Gore J, Collen D, Kleiman N, Feit F, et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology. 1995 Apr;45(4):649-58. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7723950" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, Lutsep HL, Rymer MM, Higashida RT, Starkman S, Gobin YP, Multi MERCI Investigators, Frei D, Grobelny T, Hellinger F, Huddle D, Kidwell C, Koroshetz W, Marks M, Nesbit G, Silverman IE. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008 Apr;39(4):1205-12. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18309168" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                    <p><table><tr><td>The Joint Commission. Disease-specific care certification program. Comprehensive stroke: performance measurement implementation guide. Oakbrook Terrace (IL): The Joint Commission; 2015 Mar. 278 p. </td></tr></table></p>
                    <p><table><tr><td>Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995 Dec 14;333(24):1581-7. <a href="https://web.archive.org/web/20180620213610/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7477192" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                        <h3><a href="#">Primary Health Components</a></h3>
                    <p><div class="content_para"><p>Ischemic stroke; intracranial hemorrhage; intra-venous (IV) thrombolytic (t-PA) therapy; intra-arterial (IA) t-PA therapy; mechanical endovascular reperfusion therapy</p></div></p>
                        <h3><a href="#">Denominator Description</a></h3>
                    <p><div class="content_para"><p>Ischemic stroke patients treated with intravenous (IV) thrombolytic (t-PA) therapy only (IVO) or intra-arterial (IA) t-PA therapy, or who undergo mechanical endovascular reperfusion therapy (see the related "Denominator Inclusions/Exclusions" field)</p></div></p>
                        <h3><a href="#">Numerator Description</a></h3>
                    <p><div class="content_para"><p>Ischemic stroke patients who develop a symptomatic intracranial hemorrhage less than or equal to 36 hours after the onset of treatment with intravenous (IV) thrombolytic (t-PA) therapy, or intra-arterial (IA) t-PA therapy, or mechanical endovascular reperfusion therapy</p></div></p>

            </div>
                <h2 id="573" class="accordion-title section-573 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Criterion of Quality for the Measure</a></h3>
                    <p><ul><li>A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence</li><li>A formal consensus procedure, involving experts in relevant clinical, methodological,  public health and organizational sciences</li><li>A systematic review of the clinical research literature (e.g., Cochrane Review)</li><li>One or more research studies published in a National Library of Medicine (NLM) indexed, peer-reviewed journal</li></ul></p>
                        <h3><a href="#">Additional Information Supporting Need for the Measure</a></h3>
                    <p><div class="content_para"><p>Unspecified</p></div></p>
                        <h3><a href="#">Extent of Measure Testing</a></h3>
                    <p><div class="content_para"><p>Unspecified</p></div></p>

            </div>
                <h2 id="580" class="accordion-title section-580 is-active" role="tab" aria-expanded="true"><a href="#">State of Use of the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">State of Use</a></h3>
                    <p>Current routine use</p>
                        <h3><a href="#">Current Use</a></h3>
                    <p>Certification</p>
                    <p>Collaborative inter-organizational quality improvement</p>
                    <p>Internal quality improvement</p>

            </div>
                <h2 id="583" class="accordion-title section-583 is-active" role="tab" aria-expanded="true"><a href="#">Application of the Measure in its Current Use</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Measurement Setting</a></h3>
                    <p>Hospital Inpatient</p>
                        <h3><a href="#">Professionals Involved in Delivery of Health Services</a></h3>
                    <p>Advanced Practice Nurses</p>
                    <p>Allied Health Personnel</p>
                    <p>Nurses</p>
                    <p>Pharmacists</p>
                    <p>Physician Assistants</p>
                    <p>Physicians</p>
                        <h3><a href="#">Least Aggregated Level of Services Delivery Addressed</a></h3>
                    <p>Single Health Care Delivery or Public Health Organizations</p>
                        <h3><a href="#">Statement of Acceptable Minimum Sample Size</a></h3>
                    <p>Specified</p>
                        <h3><a href="#">Target Population Age</a></h3>
                    <p><div class="content_para"><p>Age greater than or equal to 18 years</p></div></p>
                        <h3><a href="#">Target Population Gender</a></h3>
                    <p>Either male or female</p>

            </div>
                <h2 id="660" class="accordion-title section-660 is-active" role="tab" aria-expanded="true"><a href="#">National Strategy for Quality Improvement in Health Care</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">National Quality Strategy Aim</a></h3>
                    <p>Better Care</p>
                        <h3><a href="#">National Quality Strategy Priority</a></h3>
                    <p>Making Care Safer<br/>Prevention and Treatment of Leading Causes of Mortality</p>

            </div>
                <h2 id="590" class="accordion-title section-590 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Health Care Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Getting Better</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>
                    <p>Safety</p>

            </div>
                <h2 id="593" class="accordion-title section-593 is-active" role="tab" aria-expanded="true"><a href="#">Data Collection for the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Case Finding Period</a></h3>
                    <p><div class="content_para"><p>Unspecified</p></div></p>
                        <h3><a href="#">Denominator Sampling Frame</a></h3>
                    <p>Patients associated with provider</p>
                        <h3><a href="#">Denominator (Index) Event or Characteristic</a></h3>
                    <p>Clinical Condition</p>
                    <p>Institutionalization</p>
                    <p>Patient/Individual (Consumer) Characteristic</p>
                    <p>Therapeutic Intervention</p>
                        <h3><a href="#">Denominator Time Window</a></h3>
                    <p>Does not apply to this measure</p>
                        <h3><a href="#">Denominator Inclusions/Exclusions</a></h3>
                    <p><div class="content_para"><p><strong>Inclusions</strong></p>
<ul style="list-style-type: disc;">
    <li>Discharges with International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Principal Diagnosis Code for ischemic stroke as defined in the appendices of the original measure documentation
    <p class="Indent"><strong>AND</strong></p>
    </li>
    <li>Patients with documented thrombolytic (intravenous [IV] or intra-arterial [IA] thrombolytic [t-PA]) therapy (ICD-9-CM Principal or Other Procedure Codes as defined in the appendices of the original measure documentation)
    <p class="Indent"><strong>OR</strong></p>
    </li>
    <li>Patients with documented mechanical endovascular reperfusion therapy (ICD-9 CM Principal or Other Procedure Codes as defined in the appendices of the original measure documentation) </li>
</ul>
<p><strong>Exclusions</strong></p>
<ul style="list-style-type: disc;">
    <li>Patients less than 18 years of age </li>
    <li>Patients who have a Length of Stay greater than 120 days </li>
    <li>Patients admitted for <em>Elective Carotid Intervention</em> (as defined in the Data Elements) </li>
    <li>Patients transferred to the hospital following treatment with IV t-PA therapy or IA t-PA therapy or mechanical endovascular reperfusion therapy initiated prior to arrival at the hospital </li>
    <li>Patients who hemorrhage prior to the onset of treatment with IV t-PA therapy or IA t-PA therapy or mechanical endovascular reperfusion therapy </li>
</ul></div></p>
                        <h3><a href="#">Exclusions/Exceptions</a></h3>
                    <p>Medical factors addressed</p>
                    <p>Patient factors addressed</p>
                        <h3><a href="#">Numerator Inclusions/Exclusions</a></h3>
                    <p><div class="content_para"><p><strong>Inclusions</strong><br/>
Ischemic stroke patients who develop a symptomatic intracranial hemorrhage less than or equal to 36 hours after the onset of treatment with intravenous (IV) thrombolytic (t-PA) therapy, or intra-arterial (IA) t-PA therapy, or mechanical endovascular reperfusion therapy</p>
<p><strong>Exclusions</strong><br/>
None</p></div></p>
                        <h3><a href="#">Numerator Search Strategy</a></h3>
                    <p>Institutionalization</p>
                        <h3><a href="#">Data Source</a></h3>
                    <p>Administrative clinical data</p>
                    <p>Paper medical record</p>
                        <h3><a href="#">Type of Health State</a></h3>
                    <p>Adverse Health State</p>
                        <h3><a href="#">Instruments Used and/or Associated with the Measure</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>The National Institutes of Health Stroke Scale (NIHSS) </li>
    <li>Comprehensive Stroke (CSTK) Initial Patient Population Algorithm Flowchart </li>
    <li>CSTK-05: Hemorrhagic Transformation (Overall Rate) Flowchart </li>
</ul></p>

            </div>
                <h2 id="605" class="accordion-title section-605 is-active" role="tab" aria-expanded="true"><a href="#">Computation of the Measure</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Measure Specifies Disaggregation</a></h3>
                    <p>Measure is disaggregated into categories based on different definitions of the denominator and/or numerator</p>
                        <h3><a href="#">Basis for Disaggregation</a></h3>
                    <p><div class="content_para"><p>The CSTK-05 measure is reported as an overall rate which includes ischemic stroke patients who develop a symptomatic hemorrhage after reperfusion therapy. </p>
<ul style="list-style-type: disc;">
    <li><strong>CSTK-05a</strong>: Ischemic stroke patients who develop a symptomatic intracranial hemorrhage less than or equal to 36 hours after the onset of treatment with IV thrombolytic (t-PA) therapy only (IVO). </li>
    <li><strong>CSTK-05b</strong>: Ischemic stroke patients who develop a symptomatic intracranial hemorrhage less than or equal to 36 hours after the onset of treatment with IA thrombolytic (t-PA) therapy or mechanical endovascular reperfusion therapy. </li>
</ul>
<p>CSTK-05a and CSTK-05b are subsets of the overall rate, and stratified by the type of therapy.</p>
<p><strong>Data Reported As</strong>: Aggregate rate generated from count data reported as a proportion. </p></div></p>
                        <h3><a href="#">Scoring</a></h3>
                    <p>Rate/Proportion</p>
                        <h3><a href="#">Interpretation of Score</a></h3>
                    <p>Desired value is a lower score</p>
                        <h3><a href="#">Allowance for Patient or Population Factors</a></h3>
                    <p>Risk adjustment devised specifically for this measure/condition</p>
                        <h3><a href="#">Description of Allowance for Patient or Population Factors</a></h3>
                    <p><div class="content_para"><p>Risk adjustment for this measure is applied to the following data elements:</p>
<ul style="list-style-type: disc;">
    <li>Admission Date </li>
    <li>Birthdate </li>
    <li>Hispanic Ethnicity </li>
    <li>International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Other Diagnosis Codes </li>
    <li>Intravenous (IV) Thrombolytic Therapy Prior to Intra-arterial (IA) or Mechanical Reperfusion Therapy </li>
    <li>Initial Blood Glucose Value at Hospital Arrival </li>
    <li>Initial Blood Pressure at Hospital Arrival </li>
    <li>Initial National Institutes of Health Stroke Scale (NIHSS) Score at Hospital Arrival </li>
    <li>Initial Platelet Count at Hospital Arrival </li>
    <li>Race </li>
    <li>Sex </li>
</ul></div></p>
                        <h3><a href="#">Standard of Comparison</a></h3>
                    <p>Internal time comparison</p>

            </div>
                <h2 id="615" class="accordion-title section-615 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Original Title</a></h3>
                    <p><div class="content_para"><p>CSTK-05: hemorrhagic transformation (overall rate).</p></div></p>
                        <h3><a href="#">Measure Collection Name</a></h3>
                    <p>Advanced Certification in Disease-specific Care Measures</p>
                        <h3><a href="#">Measure Set Name</a></h3>
                    <p>Comprehensive Stroke Standardized Performance Measures</p>
                        <h3><a href="#">Submitter</a></h3>
                    <p>The Joint Commission - Health Care Accreditation Organization</p>
                        <h3><a href="#">Developer</a></h3>
                    <p>The Joint Commission - Health Care Accreditation Organization</p>
                        <h3><a href="#">Funding Source(s)</a></h3>
                    <p><div class="content_para"><p>All external funding for measure development has been received and used in full compliance with The Joint Commission's corporate sponsorship policies, which are available upon written request to The Joint Commission.</p></div></p>
                        <h3><a href="#">Composition of the Group that Developed the Measure</a></h3>
                    <p><div class="content_para"><p>Unspecified</p></div></p>
                        <h3><a href="#">Financial Disclosures/Other Potential Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>Expert panel members have made full disclosure of relevant financial and conflict of interest information in accordance with The Joint Commission's conflict of interest policies, copies of which are available upon written request The Joint Commission.</p></div></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>This measure was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date of Most Current Version in NQMC</a></h3>
                    <p>2015 Mar</p>
                        <h3><a href="#">Measure Maintenance</a></h3>
                    <p><div class="content_para"><p>This measure is reviewed and updated by the developing organization every 6 months.</p></div></p>
                        <h3><a href="#">Date of Next Anticipated Revision</a></h3>
                    <p><div class="content_para"><p>2015 Jul</p></div></p>
                        <h3><a href="#">Measure Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the measure.</p>
<p>The measure developer reaffirmed the currency of this measure in April 2016. </p></div></p>
                        <h3><a href="#">Source(s)</a></h3>
                    <p><table><tr><td>The Joint Commission. Disease-specific care certification program. Comprehensive stroke: performance measurement implementation guide. Oakbrook Terrace (IL): The Joint Commission; 2015 Mar. 278 p. </td></tr></table></p>
                        <h3><a href="#">Measure Availability</a></h3>
                    <p><div class="content_para"><p>Source available from <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/Home/Disclaimer?id=48910&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.jointcommission.org%2fassets%2f1%2f6%2fCSTK_Manual_Mar2015.pdf" title="The Joint Commission Web site">The Joint Commission Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/>.</p>
<p>For more information, contact The Joint Commission at One Renaissance Blvd., Oakbrook Terrace, IL 60181; Phone: 630-792-5800; Fax: 630-792-5005; Web site: <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/Home/Disclaimer?id=48910&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.jointcommission.org%2fdefault.aspx" title="The Joint Commission Web site">www.jointcommission.org</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">NQMC Status</a></h3>
                    <p><div class="content_para"><p>This NQMC summary was completed by ECRI Institute on May 19, 2015. The information was verified by the measure developer on June 22, 2015. </p>
<p>The information was reaffirmed by the measure developer on April 6, 2016. </p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NQMC summary is based on the original measure, which is subject to the measure developer's copyright restrictions. </p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NQMC Disclaimer</a></h3>
                    <p><p>The National Quality Measures Clearinghouse (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.</p> 
<p>All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.</p> 
<p>Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the <a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/inclusion-criteria">NQMC Inclusion Criteria</a>.</p> 
<p>NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding measure content are directed to contact the measure developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NQMC Measure Summaries</h3>
            <p>NQMC provides structured summaries containing information about measures and their development.</p>
            <ul>
                <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/domain-framework" class="internal-link">Domain Framework</a></li>
                <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/template-of-measure-attributes" class="internal-link">Template of Measure Attributes</a></li>
                <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about/summaries/faqs" class="help-button">Measure Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NQMC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/rssFiles/nqmc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon measure news-list-category-label">Measure Summaries</h5>
    
    <a class="block-link" href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/disclaimer?id=48910&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_footer.svg">
					  	<img src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_NQMC_footer.png" alt="NQMC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/">Home</a></li>
		                <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/browse/organization" class="parent-link">Measure Summaries</a></li>
						<li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/summaries/submit">Submit Measures</a></li>
						<li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/rss">RSS</a></li>
					    <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/browse/related">Related NGC Guidelines</a></li>
                        <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180620213610/https://www.qualitymeasures.ahrq.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
					<li><!-- NGC footer link -->
						<a href="https://web.archive.org/web/20180620213610/https://www.guideline.gov/" target="_blank" class="partner-button ngc">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_footerlink_ngc.svg">
									<img src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_footerlink_ngc.png" alt="National Guidelines Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/NGC footer link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180620213610/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180620213610im_/https://www.qualitymeasures.ahrq.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180620213610/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180620213610/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180620213610js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180620213610js_/https://www.qualitymeasures.ahrq.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 21:36:10 Jun 20, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 18:16:34 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 229.073 (3)
  esindex: 0.007
  captures_list: 260.834
  CDXLines.iter: 21.474 (3)
  PetaboxLoader3.datanode: 91.335 (4)
  exclusion.robots: 0.189
  exclusion.robots.policy: 0.178
  RedisCDXSource: 4.981
  PetaboxLoader3.resolve: 343.547 (2)
  load_resource: 259.969
-->